Récepteur couplé protéine G < Récepteur dopaminergique < Récepteur dopaminergique D1

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 37.
[0-20] [0 - 20][0 - 37][20-36][20-40]

Ident.	Authors (with country if any)	Title
000271 (2011)	Anne M. Landau [Danemark, Canada] ; M. Mallar Chakravarty [Danemark, Canada] ; Campbell M. Clark [Canada] ; Athanasios P. Zis [Canada] ; Doris J. Doudet [Danemark, Canada]	Electroconvulsive Therapy Alters Dopamine Signaling in the Striatum of Non-human Primates
000430 (2009)	Andrew R. Brown [Canada] ; BIN HU [Canada] ; Michael C. Antle [Canada] ; G. Campbell Teskey [Canada]	Neocortical movement representations are reduced and reorganized following bilateral intrastriatal 6-hydroxydopamine infusion and dopamine type-2 receptor antagonism
000621 (2007)	Daniel Levesque [Canada] ; Claude Rouillard [Canada]	Nur77 and retinoid X receptors : crucial factors in dopamine-related neuroadaptation
000669 (2007)	Manon Lebel [Canada] ; Pierre Robinson [Canada] ; Michel Cyr [Canada]	Canadian association of neurosciences review : The role of dopamine receptor function in neurodegenerative diseases
000694 (2006)	Pepijn Van Den Munckhof [Canada] ; Francois Gilbert [Canada] ; Michel Chamberland [Canada] ; Daniel Levesque [Canada] ; Jacques Drouin [Canada]	Striatal neuroadaptation and rescue of locomotor deficit by L-dopa in aphakia mice, a model of parkinson's disease
000847 (2004)	M. A. Silverdale [Royaume-Uni] ; S. L. Nicholson [Royaume-Uni] ; P. Ravenscroft [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] ; M. J. Millan [France] ; J. M. Brotchie [Canada]	Selective blockade of D3 dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate
000884 (2004)	Naila Ismayilova [Canada] ; Alan Crossman [Canada] ; Alexei Verkhratsky [Canada] ; Jonathan Brotchie [Canada]	Effects of adenosine A1, dopamine D1 and metabotropic glutamate 5 receptors-modulating agents on locomotion of the reserpinised rats
000908 (2003)	W. R. Wayne Martin [Canada] ; Marguerite Wieler [Canada]	Treatment of Parkinson's disease
000920 (2003)	Pierre J. Blanchet [États-Unis, Canada] ; Leo Verhagen Metman [États-Unis] ; Thomas N. Chase [États-Unis]	Renaissance of amantadine in the treatment of Parkinson's disease
000961 (2003)	A. Jon Stoessl [Canada] ; Raul De La Fuente-Fernandez [Canada]	Dopamine receptors in Parkinson's disease: Imaging studies
000984 (2002)	Anette V. Nieves [Canada, États-Unis] ; Anthony E. Lang [Canada]	Treatment of excessive daytime sleepiness in patients with Parkinson's Disease with modafinil
000988 (2002)	J. Q. Lu [Canada] ; A. J. Stoessl [Canada]	Somatostatin modulates the behavioral effects of dopamine receptor activation in parkinsonian rats
000A65 (2001)	Pierre J. Blanchet [Canada] ; Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Martin Goulet [Canada] ; Richard Grondin [Canada] ; Daniel Levesque [Canada] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada]	Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model
000B33 (2001)	Marco Scarselli [Italie] ; Marianna Armogida [Italie] ; Carla Pardini [Italie] ; Serena Chiacchio [Italie] ; Giovanni U. Corsini [Italie]	Apomorphine: A novel effect for an old compound
000B35 (2001)	Lana Depatie [Canada] ; Samarthji Lal [Canada]	Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?
000B37 (2001)	Kjell Fuxe [Suède] ; Ingrid Strömberg [Suède] ; Patrizia Popoli [Italie] ; Roberto Rimondini-Giorgini [Suède] ; Maria Torvinen [Suède] ; Sven O. Ögren [Suède] ; Rafael Franco [Espagne] ; Luigi F. Agnati [Italie] ; Sergi Ferre [Suède]	Adenosine receptors and Parkinson's disease: Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum
000B57 (2000)	E. F. Field [Canada] ; I. Q. Whishaw [Canada] ; S. M. Pellis [Canada]	Sex differences in catalepsy : evidence for hormone-dependent postural mechanisms in haloperidol-treated rats
000B58 (2000)	Erich Mohr [Canada] ; Tilak Mendis [Canada] ; Kathleen Hildebrand [Canada] ; Peter Paul De Deyn [Belgique]	Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: An open pilot trial
000B66 (2000)	B. J. Snow [Canada] ; F. J. G. Vingerhoets [Canada] ; J. W. Langston [États-Unis] ; J. W. Tetrud [États-Unis] ; V. Sossi [Canada] ; D. B. Calne [Canada]	Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism
000B70 (2000)	P. E. Radau [États-Unis, Canada, Allemagne] ; R. Linke ; P. J. Slomka ; K. Tatsch	Optimization of automated quantification of 123I-IBZM uptake in the striatum applied to parkinsonism
000B95 (2000)	J. M. Van Kampen [Canada] ; A. J. Stoessl [Canada]	Effects of oligonucleotide antisense to dopamine D1A receptor messenger RNA in a rodent model of levodopa-induced dyskinesia

---

List of associated Author.i

Nombre de documents	Descripteur
4	P. J. Bedard
3	A. E. Lang
3	Daniel Levesque
3	P. J. Blanchet
3	Pierre J. Blanchet
2	A. J. Stoessl
2	ABDALLAH HADJ TAHAR
2	Frédéric Calon
2	L. Gregoire
2	Marc Morissette
2	Martin Goulet
2	Paul J. Bedard
2	Richard Grondin
2	T. Di Paolo
2	Thérèse Di Paolo
1	A. Jon Stoessl
1	A. M. Lozano
1	A. R. Crossman
1	A. Sierra
1	Alan Crossman
1	Alexei Verkhratsky
1	Andrew R. Brown
1	Anette V. Nieves
1	Anne M. Landau
1	Anthony E. Lang
1	Athanasios P. Zis
1	B. Gomez-Mancilla
1	B. J. Snow
1	BIN HU
1	Campbell M. Clark
1	Carla Pardini
1	Claude Rouillard
1	D. B. Calne
1	D. Martinez-Fong
1	Doris J. Doudet
1	E. F. Field
1	E. G. Mcgeer
1	Eric Nestler
1	Erich Mohr
1	F. J. G. Vingerhoets
1	F. Tardif
1	Francois Gilbert
1	G. Campbell Teskey
1	G. Flores
1	G. G. Worth
1	George S. Robertson
1	Giovanni U. Corsini
1	H. A. Robertson
1	H. B. Niznik
1	I. Q. Whishaw
1	Ingrid Strömberg
1	J. Aceves
1	J. H. Thakar
1	J. J. Liang
1	J. M. Brotchie
1	J. M. Van Kampen
1	J. O. Dostrovsky
1	J. Q. Lu
1	J. W. Langston
1	J. W. Tetrud
1	Jacques Drouin
1	Jean-Pierre Doucet
1	Jonathan Brotchie
1	K. M. Dewar
1	K. Mizukawa
1	K. Tatsch
1	Kathleen Hildebrand
1	Kjell Fuxe
1	L. K. Srivastava
1	Lana Depatie
1	Leo Verhagen Metman
1	Luigi F. Agnati
1	M. A. Silverdale
1	M. Guttman
1	M. J. Millan
1	M. Mallar Chakravarty
1	M. N. Hassan
1	M. R. Peterson
1	Manon Lebel
1	Marco Scarselli
1	Marguerite Wieler
1	Maria Torvinen
1	Marianna Armogida
1	Michael C. Antle
1	Michel Chamberland
1	Michel Cyr
1	N. Galvez-Jimenez
1	Naila Ismayilova
1	P. Allard
1	P. E. Radau
1	P. Falardeau
1	P. J. Slomka
1	P. L. Mcgeer
1	P. Ravenscroft
1	P. Seeman
1	Patrizia Popoli
1	Pepijn Van Den Munckhof
1	Peter Paul De Deyn
1	Pierre Robinson
1	R. Boucher

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/FC03.fr.i -k "Récepteur dopaminergique" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/FC03.fr.i  \
                -Sk "Récepteur dopaminergique" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    FC03.fr.i
   |clé=    Récepteur dopaminergique
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022